BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Merck & Co., Inc. Joins Race To Copy Sanofi (France)'s Lantus

  February 11, 2014

   · 

  1 min read
• Policy

  FDA Staff: The Medicines Company’s Cangrelor Drug Should Not Be Approved

  February 11, 2014

   · 

  1 min read
• Policy

  Gilead Sciences, Inc. Seeks FDA OK Of Oral Attack On Hepatitis C

  February 11, 2014

   · 

  3 min read
• Business

  Mallinckrodt Pharmaceuticals Adds Pain Drug With $1.3 Billion Cash Cadence Pharmaceuticals, Inc. Buyout

  February 11, 2014

   · 

  15 min read
• Deals

  NephroGenex Prices IPO At Low End Of Range, Will Reap About $37.2 Million

  February 11, 2014

   · 

  3 min read
• Career Advice

  1 Cover Letter Secret That Will Guarantee You Interviews

  February 11, 2014

   · 

  3 min read
• Business

  Regeneron Reports Fourth Quarter And Full Year 2013 Financial And Operating Results

  February 11, 2014

   · 

  13 min read
• Genetown

  Ironwood Pharmaceuticals Announces Proposed Public Offering Of Common Stock

  February 11, 2014

   · 

  4 min read
• Drug Development

  Alba Therapeutics Corporation Announces Positive Results Of Phase 2b Trial In Celiac Disease

  February 11, 2014

   · 

  5 min read
• Biotech Bay

  Cepheid Announces Closing Of $345 Million Of 1.25% Convertible Senior Notes Due 2021

  February 11, 2014

   · 

  2 min read